药物对比
Saxagliptin vs Insulin Icodec
Saxagliptin 与 Insulin Icodec：口服DPP-4抑制剂与每周一次胰岛素类似物治疗2型糖尿病。比较作用机制、给药方式、疗效和患者适配性。
此页面暂无可用的对比维度。
临床背景
Patients with type 2 diabetes considering transitioning from oral antidiabetics like DPP-4 inhibitors to insulin therapy.
结论
Saxagliptin suits oral therapy seekers, Insulin Icodec those requiring weekly basal insulin, based on disease progression.
全部药物对比